Table 4.
GH % |
PE % |
CH % |
Total HDP N (%) |
|
Total N | 15 | 143 | 16 | 174 |
Preference of discussion topics* | ||||
Impact on my children from the pregnancy affected by HDP | 73 | 80 | 63 | 136 (73) |
Signs and Symptoms of the conditions | 80 | 71 | 69 | 124 (67) |
Risk reduction for subsequent pregnancy | 40 | 62 | 44 | 101 (54) |
When does the risk rise | 40 | 61 | 50 | 101 (54) |
Statistics | 40 | 60 | 38 | 98 (53) |
Reducing risk behaviours (diet, exercise, smoking cessation) | 40 | 56 | 31 | 91 (49) |
Where to find information | 40 | 51 | 13 | 81 (44) |
How to discuss the matter with my healthcare provider | 27 | 40 | 25 | 65 (35) |
Preference of distribution* | ||||
Medical professionals | 73 | 82 | 75 | 140 (80) |
Key organisations | 53 | 61 | 63 | 105 (60) |
Social media | 40 | 51 | 19 | 82 (47) |
Brochures/flyers | 40 | 45 | 31 | 75 (43) |
Online videos | 20 | 24 | 25 | 42 (24) |
Podcast/media | 13 | 23 | 25 | 39 (22) |
*Table represents frequency of each option; percentages add to over 100% as women were asked to select any/all that applied.
CH, chronic hypertension worsening in pregnancy and/or with superimposed PE; GH, gestational hypertension; HDP, hypertensive disorders of pregnancy; PE, pre-eclampsia.